Canada mRNA Synthesis & Manufacturing Market (2024-2029)
The Canada mRNA Synthesis & Manufacturing Market was valued at $90.9 Million in 2024 and projected to reach to $110.6 Million by 2029, representing a compound annual growth rate of 4.0%. Canada's mRNA synthesis and manufacturing market is poised for sustained growth through 2029, driven by expanding biopharmaceutical investments and government support for life sciences innovation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada mRNA Synthesis & Manufacturing Market Trends and Insights
- This steady growth reflects Canada's strengthening position in the global biopharmaceutical supply chain, driven by increasing investments in mRNA-based therapeutics and vaccine development.
- Canada's advanced research infrastructure and regulatory framework support the expansion of domestic manufacturing capabilities for mRNA products. The Canadian market benefits from government initiatives promoting biotechnology innovation and the country's proximity to major North American pharmaceutical markets.
- Between 2024 and 2029, Canada is expected to see growing demand for contract manufacturing services and specialized synthesis equipment as pharmaceutical companies establish or expand mRNA production facilities.
- Canada's skilled workforce and established life sciences ecosystem position the nation as an attractive hub for mRNA manufacturing investments in North America..
Key Market Statistics
- CAGR (2024-2029) 4.0% CAGR
- Market Size, 2024 ~USD 90.9 Million
- Forecast, 2029 ~USD 110.6 Million
- Country Canada
Canada mRNA Synthesis & Manufacturing Market Overview
Market Valuation :
Canada's mRNA synthesis and manufacturing market reached $90.9 million in 2024, with projections to grow to $110.6 million by 2029, representing a steady 4.0% CAGR.
Supply Chain Integration :
Canada is strengthening its position in the global biopharmaceutical supply chain through strategic investments in mRNA manufacturing infrastructure and capacity expansion.
Therapeutic Development :
Increased investments in mRNA-based therapeutics and vaccine development are driving market growth, positioning Canada as a key player in next-generation medicine manufacturing.
Competitive Advantages :
Canada's regulatory framework, skilled workforce, and proximity to North American markets provide distinct advantages for mRNA synthesis and manufacturing operations.
Canada mRNA Synthesis & Manufacturing Market Dynamics
- The country's established regulatory infrastructure and access to capital are attracting both domestic and international mRNA manufacturers seeking to diversify production capacity beyond traditional hubs. The 4.0% CAGR reflects moderate but consistent expansion as Canadian facilities scale operations to meet growing demand for mRNA therapeutics and vaccines.
- Strategic partnerships with global pharmaceutical companies and continued R&D investments will further strengthen Canada's role in the mRNA supply chain, supporting both domestic healthcare needs and international market opportunities..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Canada's mRNA synthesis & manufacturing market is valued at $90.9 million in 2024 and will reach $110.6 million by 2029 at a 4.0% CAGR.
- Canada's advanced regulatory framework and research infrastructure support the growth of domestic mRNA manufacturing capabilities.
- Government support and biotechnology initiatives in Canada are driving investment in mRNA-based therapeutics and vaccine production.
- Canada's strategic location and skilled workforce make it an attractive destination for North American mRNA manufacturing expansion.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Canada mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 16.4 | 14.1 | 14 | 14.4 | 15.1 | 16 | 17 | 18.5 | 5.7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 47.1 | 40.5 | 40.4 | 41.8 | 44.1 | 46.8 | 50 | 54.5 | 6.2 |
| SMALL-SCALE CROS & CDMOS | 6 | 5.1 | 5 | 5.1 | 5.3 | 5.6 | 5.9 | 6.3 | 4.8 |
| TOTAL | 69.4 | 59.6 | 59.4 | 61.3 | 64.6 | 68.4 | 73 | 79.3 | 5.9 |
CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 29.6 | 21.5 | 21.4 | 22 | 22.8 | 23.7 | 24.7 | 26 | 3.9 |
| CROS & CDMOS | 25.6 | 18.6 | 18.5 | 18.9 | 19.6 | 20.4 | 21.1 | 22.2 | 3.7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 70.1 | 51 | 51 | 52.4 | 54.6 | 56.9 | 59.2 | 62.5 | 4.2 |
| TOTAL | 125.3 | 91.1 | 90.9 | 93.3 | 97.1 | 101 | 105 | 110.6 | 4 |
Target Audience
- Biopharmaceutical Manufacturers : Evaluate Canada as a manufacturing hub for mRNA therapeutics and vaccines, assess capacity expansion opportunities, and identify partnership or acquisition targets in the Canadian market.
- Investment & Private Equity Firms : Identify high-growth investment opportunities in Canadian mRNA synthesis companies, assess market valuation trends, and benchmark returns against global mRNA manufacturing investments.
- Government & Policy Makers : Develop evidence-based policies supporting mRNA manufacturing growth, allocate R&D funding effectively, and strengthen Canada's competitive position in the global biopharmaceutical supply chain.
- Contract Manufacturing Organizations (CMOs) : Understand Canadian market demand for mRNA manufacturing services, identify capacity gaps, and plan facility investments to capture growing therapeutic and vaccine production volumes.
- Healthcare & Pharmaceutical Consultants : Provide clients with authoritative Canada-specific market data, competitive analysis, and strategic recommendations for mRNA-related business development and market positioning.
Reasons to Buy this Report
- Market-Specific Sizing : Access precise valuation data for Canada's mRNA synthesis market with verified 2024 baseline ($90.9M) and 2029 forecasts ($110.6M), enabling accurate budget allocation and investment planning.
- Competitive Landscape Intelligence : Understand Canada's unique position within the global mRNA manufacturing ecosystem, including local advantages, regulatory environment, and competitive differentiation versus other regions.
- Growth Driver Analysis : Identify key factors fueling Canada's 4.0% CAGR, including government initiatives, private sector investments, and therapeutic pipeline developments specific to the Canadian market.
- Strategic Expansion Planning : Leverage country-specific insights to evaluate market entry opportunities, facility location decisions, and partnership strategies tailored to Canada's biopharmaceutical ecosystem.
- Regulatory & Operational Insights : Gain detailed understanding of Canada's manufacturing capabilities, regulatory pathways, workforce availability, and infrastructure readiness for mRNA production scaling.
Frequently asked questions
What is the current size of Canada's mRNA synthesis and manufacturing market?
Canada's mRNA synthesis and manufacturing market was valued at $90.9 million in 2024, with expectations to grow to $110.6 million by 2029.
What is the projected growth rate for Canada's mRNA market through 2029?
Canada's mRNA synthesis and manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2029.
What factors are driving growth in Canada's mRNA manufacturing sector?
Growth in Canada is driven by government biotechnology initiatives, increasing investments in mRNA therapeutics, vaccine development programs, and the expansion of contract manufacturing services.
Why is Canada an attractive location for mRNA manufacturing?
Canada offers advanced research infrastructure, a robust regulatory framework, a skilled workforce, government support for biotechnology, and strategic proximity to major North American pharmaceutical markets.
What is the forecast market size for Canada's mRNA synthesis market in 2029?
Canada's mRNA synthesis and manufacturing market is projected to reach $110.6 million by 2029, representing growth of $19.7 million from the 2024 baseline.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
